HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alex Yaroshinsky Selected Research

malassezin

2/2022Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation.
1/2022A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alex Yaroshinsky Research Topics

Disease

5Heart Failure
01/2019 - 07/2011
3Heart Diseases (Heart Disease)
02/2014 - 07/2011
2Hyperpigmentation
02/2022 - 01/2022
2Acne Vulgaris
01/2006 - 01/2005
1Melanosis (Freckles)
02/2022
1Myotonic Dystrophy (Dystrophia Myotonica)
11/2020
1Fragile X Syndrome (Martin Bell Syndrome)
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Rett Syndrome (Rett's Disorder)
11/2017
1Stress Fractures (Stress Fracture)
10/2015
1Actinic Keratosis
01/2015
1Condylomata Acuminata (Genital Wart)
11/2014
1Atrial Fibrillation
02/2014
1Frailty
02/2014
1Myocardial Infarction
01/2014
1Ventricular Remodeling
07/2011

Drug/Important Bio-Agent (IBA)

3CalciumIBA
02/2014 - 07/2011
2malassezinIBA
02/2022 - 01/2022
2trofinetideIBA
01/2020 - 11/2017
2Brain Natriuretic Peptide (Natrecor)FDA Link
02/2014 - 07/2011
2Adenosine Triphosphatases (ATPase)IBA
02/2014 - 07/2011
2Biomarkers (Surrogate Marker)IBA
02/2014 - 07/2011
2Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
01/2014 - 07/2011
2Clindamycin (Cleocin)FDA LinkGeneric
01/2006 - 01/2005
1indoleIBA
02/2022
1tideglusibIBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1Biological ProductsIBA
01/2019
1salicylhydroxamic acid (SHAM)IBA
01/2019
1candesartanIBA
01/2016
1CollagenIBA
10/2015
1Coloring Agents (Dyes)IBA
10/2015
1Fluconazole (Zonal)FDA LinkGeneric
10/2015
1safranine T (safranin)IBA
10/2015
1Collagen Type II (Type II Collagen)IBA
10/2015
13-ingenyl angelateIBA
01/2015
1Ointments (Pastes)IBA
11/2014
1Protein Isoforms (Isoforms)IBA
02/2014
1Deoxyribonucleases (DNase)FDA Link
01/2014
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2006
1Pharmaceutical PreparationsIBA
01/2006
1tretinoin drug combination clindamycinIBA
01/2006
1HydrogelsIBA
01/2006
1Anti-Bacterial Agents (Antibiotics)IBA
01/2005
1clindamycin phosphate (Clindets)FDA LinkGeneric
01/2005

Therapy/Procedure

4Therapeutics
11/2017 - 01/2014
3Cutaneous Administration
02/2014 - 07/2011
2Heart-Assist Devices
02/2014 - 01/2014
1Immunotherapy
01/2019
1Investigational Therapies (Experimental Therapy)
01/2019
1Cryotherapy (Therapy, Cold)
11/2014
1Heart Transplantation (Grafting, Heart)
01/2014